Tirzepatide
GIP / GLP-1 receptor co-agonist. C20 fatty diacid moiety.
35 lyophilized compounds and reagents for in-vitro work, each lot backed by a manufacturer certificate of analysis. Priced in CAD, paid by Interac e-Transfer, shipped tracked anywhere in Canada.
GIP / GLP-1 receptor co-agonist. C20 fatty diacid moiety.
GIP / GLP-1 / glucagon receptor tri-agonist. Investigational.
GLP-1 receptor agonist. Aib8 substitution, C18 diacid side chain.
Pentadecapeptide, partial sequence of body protection compound.
Synthetic thymosin β4 fragment containing the LKKTETQ actin-binding motif.
Gly-His-Lys copper(II) complex.
N-hexenoyl GHRH (1–44) amide.
Elamipretide. D-Arg-Dmt-Lys-Phe-NH2, cardiolipin-binding.
Choose a compound, a vial size and a quantity. Multi-vial pricing applies automatically.
Checkout issues a reference (YVR-…) and the exact amount, including tax for your province.
Send an Interac e-Transfer with the reference in the message. Orders dispatch once payment is confirmed.
Find the lot number on the vial and look up its certificate of analysis on the COA page.
Each lot ships with a manufacturer-issued COA (HPLC purity, mass spectrometry identity). Reports are indexed by lot number as we receive them.
$15 flat, free over $150. Plain outer packaging. Dispatched by our fulfilment partner in one to two business days after payment.
Not approved by Health Canada. No DIN. Not for human or veterinary use. We do not provide dosing or administration information.